Hutchison China Meditech Share Price (HCM)

4,245.00 +45.00 (+1.07%) delayed: 10:38AM BST
Bid price 4,200.00 Open price 4,220.00
Ask price 4,290.00 Prev close 4,245.00
High price 4,325.00 Spread 2.10%
Low price 4,220.00 Volume 5,563

Register now for FREE live Hutchison China Meditech share prices, Hutchison China Meditech stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Hutchison China Meditech Level 2 Data, indepth research tools and investor commentary for Hutchison China Meditech (HCM) and other London Stock Exchange equities.

Hutchison China Meditech Share Price Chart

Advanced Charts >>

Register now for FREE Hutchison China Meditech share price charts

Hutchison China Meditech Share Price Information

Name Hutchison China Meditech Epic HCM
Sector Pharmaceuticals & Biotechnology ISIN KYG4672N1016
Activites Hutchison China MediTech Limited (Chi-Med) is the holding company of a pharmaceutical and healthcare group based primarily in China. Chi-Med is a subsidiary of Hutchison Whampoa Ltd., an international corporation listed on the Main Board of the Hong Kong Stock Exchange which had an annual turnover of approximately US$50 billion in 2011 and over a quarter million employees in 53 countries worldwide as at 31 December 2011. Chi-Med focuses on researching, developing, manufacturing and selling pharmaceuticals, and health oriented consumer products primarily in the China market. Chi-Med was established in 2000 as a wholly-owned subsidiary of HWL. Index n/a

Hutchison China Meditech Key Numbers

Latest Share Price (p) 4,245.00 Net Gearing (%) 17.21
Market Capitalisation (£m) 2,700.34 Gross Gearing (%) 40.41
Shares in issue (m) 60.75 Debt Ratio 17.49
P/E Ratio 222.25 Debt-to-Equity Ratio 0.31
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.68
Dividend Yield (%) 0.00 Price to book value 13.23
Dividend cover (x) 0.00 ROCE (%) 5.89
Earning per share (p) 20.00 EPS Growth (%) 131.25
52 week high / low 4,570.00 / 1,817.50 DPS Growth (%) n/a

Hutchison China Meditech Director Deals

Dec.Date Type Director Pos No. of Shares
07/08/2017 BUY Dr Dan Eldar NED 1,900
07/08/2017 BUY Paul Carter NED 724
29/03/2017 TIN Christian Hogg CEO 5,620
20/03/2017 BUY Paul Carter NED 2,800
23/11/2016 SELL Michael Howell RES 10,000

More Hutchison China Meditech Director Deals >>

Hutchison China Meditech Company News

09:20 19/10/2017

Notification of Major Interest in Shares

RNS Number : 0668U Hutchison China Meditech Limited 19 October 2017       TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi     1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:...

09:54 17/10/2017

Chi-Med and AZ present encouraging data on lung cancer drug

Hutchison China Meditech has announced that savolitinib - the lung cancer drug being developed in collaboration with AstraZeneca - had shown encouraging clinical activity. Chi-Med and AstraZeneca presented preliminary safety and clinical activity data of savolitinib when given in combination...

07:00 17/10/2017

Savolitinib Shows Encouraging Clinical Activity

RNS Number : 7831T Hutchison China Meditech Limited 17 October 2017   Chi-Med and AstraZeneca's Savolitinib Shows Encouraging Clinical Activity in Second-Line EGFR Mutation-Positive Lung Cancer with MET -Amplification - Data for savolitinib in combination with Tagrisso® or...

More Hutchison China Meditech Company News >>

Register now for FREE Hutchison China Meditech company news

Hutchison China Meditech Share Price Discussions

5 days ago

Hutchison China Meditech (HCM)

Hutchison China MediTech Limited ("Chi-Med") is a China-based globally-focused healthcare group which researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing innovative therapeutics in...

Register now for FREE Hutchison China Meditech share price discussions